Array
(
[id] => 504
[catid] => 247
[title] => Guidelines on pediatric day surgery of the Italian Societies of Pediatric Surgery (SICP) and Pediatric Anesthesiology (SARNePI)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/504.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:41
[updatetime] => 2024-01-11 15:12:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => CEVeAS分级
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => Italian Societies of Pediatric Surgery (SICP) and
[pdf] =>
[tjyjyw] =>
[lyyw] => PONV prevention requests a multifactorial approach that includes pre-operative identification of risk factors (family history, age> 3yrs.Strabismus Repair and ORL surgery). In patients at risk prophylaxis is recommended (i.e.ondansetron 0.05 mg/kg + dexametason 0.015 mg/kg). (I A)
[laiyuan] => PONV的预防需要多因素的方法，包括术前危险因素的识别(家族史，年龄>3岁，斜视修复和ORL手术)。对于有风险的患者，建议采取预防措施(即:昂丹司琼0.05 mg/kg +地塞米松0.015 mg/kg)。（证据等级：I ；推荐强度：A）
[znzldj] => B
[_inputtime] => 1704957161
[_updatetime] => 1704957161
[_nrjc] =>
[_nrsh] =>
)
推荐意见
PONV的预防需要多因素的方法，包括术前危险因素的识别(家族史，年龄>3岁，斜视修复和ORL手术)。对于有风险的患者，建议采取预防措施(即:昂丹司琼0.05 mg/kg +地塞米松0.015 mg/kg)。（证据等级：I ；推荐强度：A）
PONV prevention requests a multifactorial approach that includes pre-operative identification of risk factors (family history, age> 3yrs.Strabismus Repair and ORL surgery). In patients at risk prophylaxis is recommended (i.e.ondansetron 0.05 mg/kg + dexametason 0.015 mg/kg). (I A)
证据评价方法：CEVeAS分级
指南质量等级：B
年份：2018
国家：Italian Societies of Pediatric Surgery (SICP) and
Array
(
[id] => 505
[catid] => 238
[title] => Guidelines on pediatric day surgery of the Italian Societies of Pediatric Surgery (SICP) and Pediatric Anesthesiology (SARNePI)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/505.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:41
[updatetime] => 2024-01-11 15:12:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => CEVeAS分级
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => Italian Societies of Pediatric Surgery (SICP) and
[pdf] =>
[tjyjyw] =>
[lyyw] => The administration of clear fluids up to two hours before induction is advised. This lower the residual gastric volume and raise pH. (I A)
[laiyuan] => 建议在诱导前两小时服用清亮液体。这降低了胃残量，提高了pH值。（证据等级：I；推荐强度：A）
[znzldj] => B
[_inputtime] => 1704957161
[_updatetime] => 1704957161
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议在诱导前两小时服用清亮液体。这降低了胃残量，提高了pH值。（证据等级：I；推荐强度：A）
The administration of clear fluids up to two hours before induction is advised. This lower the residual gastric volume and raise pH. (I A)
证据评价方法：CEVeAS分级
指南质量等级：B
年份：2018
国家：Italian Societies of Pediatric Surgery (SICP) and
Array
(
[id] => 455
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/455.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:40
[updatetime] => 2024-01-11 15:12:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend a postoperative hemoglobin threshold for transfusion in stable acyanotic cardiac children of Hb 70 g/L, or 80 g/L in the presence of clinical signs suggestive of symptomatic anemia. (1B)
[laiyuan] => 建议稳定型紫绀型心脏病患儿术后输血的血红蛋白阈值为Hb 70g/L，如果有临床症状提示症状性贫血，则为80g/L。（证据等级：中；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957160
[_updatetime] => 1704957160
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议稳定型紫绀型心脏病患儿术后输血的血红蛋白阈值为Hb 70g/L，如果有临床症状提示症状性贫血，则为80g/L。（证据等级：中；推荐强度：强推荐）
We recommend a postoperative hemoglobin threshold for transfusion in stable acyanotic cardiac children of Hb 70 g/L, or 80 g/L in the presence of clinical signs suggestive of symptomatic anemia. (1B)
证据评价方法：GRADE
指南质量等级：B
年份：2019
国家：the Network for the Advancement of Patient Blood M
Array
(
[id] => 456
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/456.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:40
[updatetime] => 2024-01-11 15:12:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest viscoelastic tests as an alternative to standard coagulation assays for intraoperative bleeding management. (2C)
[laiyuan] => 建议将血栓弹力图作为术中出血管理标准凝血测定的替代方法。（证据等级：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957160
[_updatetime] => 1704957160
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议将血栓弹力图作为术中出血管理标准凝血测定的替代方法。（证据等级：低；推荐强度：弱推荐）
We suggest viscoelastic tests as an alternative to standard coagulation assays for intraoperative bleeding management. (2C)
证据评价方法：GRADE
指南质量等级：B
年份：2019
国家：the Network for the Advancement of Patient Blood M
Array
(
[id] => 457
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/457.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:40
[updatetime] => 2024-01-11 15:12:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that intraoperative monitoring of hemostasis should be integrated into institutionspecific transfusion algorithms. (2C)
[laiyuan] => 建议将术中止血监测纳入特定机构的输血算法。（证据等级：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957160
[_updatetime] => 1704957160
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议将术中止血监测纳入特定机构的输血算法。（证据等级：低；推荐强度：弱推荐）
We suggest that intraoperative monitoring of hemostasis should be integrated into institutionspecific transfusion algorithms. (2C)
证据评价方法：GRADE
指南质量等级：B
年份：2019
国家：the Network for the Advancement of Patient Blood M
Array
(
[id] => 458
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/458.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:40
[updatetime] => 2024-01-11 15:12:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => In the presence of excessive bleeding, we recommend the use of intraoperative monitoring of hemostasis to guide the administration of blood products. (1B)
[laiyuan] => 在出血过多的情况下，建议使用术中止血监测来指导血液制品的使用。（证据等级：中；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957160
[_updatetime] => 1704957160
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在出血过多的情况下，建议使用术中止血监测来指导血液制品的使用。（证据等级：中；推荐强度：强推荐）
In the presence of excessive bleeding, we recommend the use of intraoperative monitoring of hemostasis to guide the administration of blood products. (1B)
证据评价方法：GRADE
指南质量等级：B
年份：2019
国家：the Network for the Advancement of Patient Blood M
Array
(
[id] => 459
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/459.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:40
[updatetime] => 2024-01-11 15:12:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend the use of DTIs when heparin is contraindicated. (1C)
[laiyuan] => 建议在肝素禁忌症时使用肠外直接凝血酶抑制剂（DTIs）。（证据等级：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957160
[_updatetime] => 1704957160
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议在肝素禁忌症时使用肠外直接凝血酶抑制剂（DTIs）。（证据等级：低；推荐强度：强推荐）
We recommend the use of DTIs when heparin is contraindicated. (1C)
证据评价方法：GRADE
指南质量等级：B
年份：2019
国家：the Network for the Advancement of Patient Blood M
Array
(
[id] => 460
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/460.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:40
[updatetime] => 2024-01-11 15:12:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest against the use of a protamine-to-heparin ratio of 1:1 or higher as protamine in excess could increase the risk of bleeding. (2C)
[laiyuan] => 建议不要使用质胺与肝素的比例为 1:1 或更高，因为过量使用质胺会增加出血风险。（证据等级：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957160
[_updatetime] => 1704957160
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议不要使用质胺与肝素的比例为 1:1 或更高，因为过量使用质胺会增加出血风险。（证据等级：低；推荐强度：弱推荐）
We suggest against the use of a protamine-to-heparin ratio of 1:1 or higher as protamine in excess could increase the risk of bleeding. (2C)
证据评价方法：GRADE
指南质量等级：B
年份：2019
国家：the Network for the Advancement of Patient Blood M
Array
(
[id] => 461
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/461.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:40
[updatetime] => 2024-01-11 15:12:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend the dose of protamine should be calculated based on heparin concentration. (1C)
[laiyuan] => 建议应根据肝素浓度计算质胺剂量。（证据等级：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957160
[_updatetime] => 1704957160
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议应根据肝素浓度计算质胺剂量。（证据等级：低；推荐强度：强推荐）
We recommend the dose of protamine should be calculated based on heparin concentration. (1C)
证据评价方法：GRADE
指南质量等级：B
年份：2019
国家：the Network for the Advancement of Patient Blood M
Array
(
[id] => 462
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/462.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:40
[updatetime] => 2024-01-11 15:12:40
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend fresh frozen plasma (10 mL/kg) or antithrombin supplementation in the presence of heparin resistance secondary to antithrombin deficiency. (1C)
[laiyuan] => 如果因抗凝血酶缺乏导致肝素抵抗，推荐使用新鲜冰冻血浆（10mL/kg）或补充抗凝血酶。（证据等级：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957160
[_updatetime] => 1704957160
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果因抗凝血酶缺乏导致肝素抵抗，推荐使用新鲜冰冻血浆（10mL/kg）或补充抗凝血酶。（证据等级：低；推荐强度：强推荐）
We recommend fresh frozen plasma (10 mL/kg) or antithrombin supplementation in the presence of heparin resistance secondary to antithrombin deficiency. (1C)
证据评价方法：GRADE
指南质量等级：B
年份：2019
国家：the Network for the Advancement of Patient Blood M
